Information Library
Results for: Enrollment & retention - Product Development & Commercialization
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT
Press Release — May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program
-
Regulatory Landscapes for Future Antidiabetic Drug Development
Hear from the Experts — May 12, 2010
In the March 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the EMA Guidance on diabetes drugs and cardiovascular risk. -
FDA Requirements for Clinical Studies in Pediatric Patients
White Paper — April 1, 2010
FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy -
Propelling Pediatric Research
Case Study — April 1, 2010
Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study -
Boosting Pediatric Enrollment
Case Study — April 1, 2010
Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks. -
Anticipating the Challenge
Case Study — March 3, 2010
Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study. -
Advancing Innovation
Case Study — March 3, 2010
Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales. -
Alzheimer's Inroads
Case Study — March 3, 2010
A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site. -
Trumping Expectations
Case Study — March 1, 2010
Quintiles sails past recruitment hurdles with tailored approaches that build momentum -
Sub-Saharan Africa Phase II/III Fact Sheet
Brochure — July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.
